Cargando…

pH of anti-VEGF agents in the human vitreous: low impact of very different formulations

BACKGROUND: The aim of the study was to measure pH changes of the human vitreous caused by the intravitreal drugs bevacizumab, ranibizumab, aflibercept, and ziv-aflibercept. METHODS: Fresh human vitreous samples were obtained during core vitrectomy (23-gauge) from patients with epiretinal gliosis. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sobolewska, Bianka, Heiduschka, Peter, Bartz-Schmidt, Karl-Ulrich, Ziemssen, Focke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483844/ https://www.ncbi.nlm.nih.gov/pubmed/28652928 http://dx.doi.org/10.1186/s40942-017-0075-x

Ejemplares similares

Correction to: pH of anti-VEGF agents in the human vitreous: low impact of very different formulations
por: Sobolewska, Bianka, et al.
Publicado: (2017)

Importance of Treatment Duration: Unmasking Barriers and Discovering the Reasons for Undertreatment of Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration
por: Sobolewska, Bianka, et al.
Publicado: (2021)

Submacular predominantly hemorrhagic choroidal neovascularization: resolution of bleedings under anti-VEGF therapy
por: Dimopoulos, Spyridon, et al.
Publicado: (2015)

Human Platelets Take up Anti-VEGF Agents
por: Sobolewska, B., et al.
Publicado: (2021)

Using a slit lamp-mounted digital high-speed camera for dynamic observation of phakic lenses during eye movements: a pilot study
por: Leitritz, Martin Alexander, et al.
Publicado: (2014)

Seroprävalenz und SARS-CoV-2-Testung in Gesundheitsberufen
por: Ziemssen, Focke, et al.
Publicado: (2020)

Vitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy
por: Agrawal, Shivi, et al.
Publicado: (2013)

Legal obligation in the general population: face mask influence on endophthalmitis after intravitreal injection
por: Neubauer, Jonas, et al.
Publicado: (2022)

Treatment of age-related macular degeneration: focus on ranibizumab
por: Spitzer, Martin S, et al.
Publicado: (2008)

Adhärenz bei der Anti-VEGF-Therapie – Überlegungen und praktische Empfehlungen
por: Lommatzsch, Albrecht, et al.
Publicado: (2020)

Morphometric Optic Nerve Head Analysis in Glaucoma Patients: A Comparison between the Simultaneous Nonmydriatic Stereoscopic Fundus Camera (Kowa Nonmyd WX3D) and the Heidelberg Scanning Laser Ophthalmoscope (HRT III)
por: Mariacher, Siegfried, et al.
Publicado: (2016)

A swarm of slippery micropropellers penetrates the vitreous body of the eye
por: Wu, Zhiguang, et al.
Publicado: (2018)

Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centre
por: Ziemssen, Focke, et al.
Publicado: (2021)

Peptide Nanofiber System for Sustained Delivery of Anti-VEGF Proteins to the Eye Vitreous
por: Yaylaci, Seher, et al.
Publicado: (2023)

Reporting of Safety Events during Anti-VEGF Treatment: Pharmacovigilance in a Noninterventional Trial
por: Ziemssen, Focke, et al.
Publicado: (2020)

Ex vivo biophysical characterization of a hydrogel-based artificial vitreous substitute
por: Januschowski, Kai, et al.
Publicado: (2019)

Dual pH durability studies of man-made vitreous fiber (MMVF).
por: Bauer, J F, et al.
Publicado: (1994)

Laser photocoagulation, intravitreal anti-VEGF, and vitreous surgery for the treatment of juxtapapillary retinal capillary hemangioma
por: Ucan Gunduz, Gamze, et al.
Publicado: (2019)

Outcomes of 23-Gauge Vitrectomy Combined with Phacoemulsification, Panretinal Photocoagulation, and Trabeculectomy without Use of Anti-VEGF Agents for Neovascular Glaucoma with Vitreous Hemorrhage
por: Yan, Hua
Publicado: (2016)

Effect of prophylactic anti-VEGF injections on the prevention of recurrent vitreous hemorrhage in PDR patients after PRP
por: Lim, Jae Wan, et al.
Publicado: (2022)

Dangers of very low blood pH
por: Rosival, Viktor
Publicado: (2011)

Severe acute respiratory Syndrome-Coronavirus-2: Can it be detected in the retina?
por: Bayyoud, Tarek, et al.
Publicado: (2021)

Microenvironment Changes (in pH) Affect VEGF Alternative Splicing
por: Elias, Ana Paula, et al.
Publicado: (2008)

pH-Dependent Antibacterial Activity of Glycolic Acid: Implications for Anti-Acne Formulations
por: Valle-González, Elba R., et al.
Publicado: (2020)

Development of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology
por: Trujillo, Cleber A, et al.
Publicado: (2007)

Anti-VEGF Agents and Glaucoma Filtering Surgery
por: Daneshvar, Ramin
Publicado: (2013)

Use of Anti-VEGF Agents in Glaucoma Surgery
por: Slabaugh, Mark, et al.
Publicado: (2017)

Dietary Intervention With a Targeted Micronutrient Formulation Reduces the Visual Discomfort Associated With Vitreous Degeneration
por: Ankamah, Emmanuel, et al.
Publicado: (2021)

Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF(165)b Isoform in the Vitreous of Patients with Retinopathy of Prematurity
por: Zhao, Min, et al.
Publicado: (2015)

Risk factors for breakthrough vitreous hemorrhage after intravitreal anti-VEGF injection in age-related macular degeneration with submacular hemorrhage
por: Shin, Yong-Il, et al.
Publicado: (2018)

microRNA Expression Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients and Differences from Patients Treated with Anti-VEGF Therapy
por: Friedrich, Julian, et al.
Publicado: (2020)

Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients
por: Izuta, Hiroshi, et al.
Publicado: (2009)

VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy Patients
por: Rezzola, Sara, et al.
Publicado: (2021)

Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability
por: Kimoto, Kenichi, et al.
Publicado: (2012)

Quantifying Conflict of Interest in the Choice of Anti-VEGF Agents
por: Browning, David J, et al.
Publicado: (2021)

The role of Anti-VEGF agents in treatment of neovascular glaucoma
por: Palfi (Salavat), Mădălina-Casiana, et al.
Publicado: (2022)

Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body
por: Izuta, Hiroshi, et al.
Publicado: (2010)

Vitreous and Plasma VEGF Levels as Predictive Factors in the Progression of Proliferative Diabetic Retinopathy after Vitrectomy
por: Wang, Jiaxing, et al.
Publicado: (2014)

Bevacizumab: Off-label use in ophthalmology
por: Grisanti, Salvatore, et al.
Publicado: (2007)

Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapies
por: Faes, Seraina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tl68ujvqe3n131phlvpvjs4isg